INTERNATIONAL PATENT: MEDINCELL S.A. FILES APPLICATION FOR "A METHOD FOR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLE IN TOTAL KNEE REPLACEMENT"

GENEVA, Nov. 3 -- MEDINCELL S.A. (3 rue des Freres Lumiere34830 Jacou) filed a patent application (PCT/EP2025/061376) for "A METHOD FOR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLE IN TOTAL KNEE REPLACEMENT" on Apr 25, 2025. With publication no. WO/2025/224317, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHIVE, Matthew (1130 Leyden StreetDenver, Colorado 80220)

Abstract: A method of treating or managing pain or inflammation in a patient following a total knee replacement (TKR) by administering to the knee joint of sai...